Palivizumab epitope–displaying virus-like particles protect rodents from RSV challenge

Respiratory syncytial virus (RSV) is the most common cause of serious viral bronchiolitis in infants, young children, and the elderly. Currently, there is not an FDA-approved vaccine available for RSV, though the mAb palivizumab is licensed to reduce the incidence of RSV disease in premature or at-r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Clin Invest
Hauptverfasser: Schickli, Jeanne H., Whitacre, David C., Tang, Roderick S., Kaur, Jasmine, Lawlor, Heather, Peters, Cory J., Jones, Joyce E., Peterson, Darrell L., McCarthy, Michael P., Van Nest, Gary, Milich, David R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Clinical Investigation 2015
Schlagworte:
Technical Advance
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4409022/
https://ncbi.nlm.nih.gov/pubmed/25751145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI78450
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge